Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Krishna Nalleballe

Concepts (163)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Stroke
14
2022
520
2.370
 Why?
Thrombolytic Therapy
4
2022
114
1.170
 Why?
Pneumonia, Viral
6
2020
177
1.170
 Why?
Fibrinolytic Agents
4
2022
132
1.160
 Why?
Coronavirus Infections
6
2020
188
1.150
 Why?
Tissue Plasminogen Activator
3
2020
108
1.130
 Why?
Pandemics
8
2020
595
0.760
 Why?
Endovascular Procedures
2
2022
193
0.740
 Why?
Cavernous Sinus
1
2022
15
0.720
 Why?
Carotid-Cavernous Sinus Fistula
1
2022
11
0.720
 Why?
Embolization, Therapeutic
1
2022
91
0.670
 Why?
Conflict of Interest
2
2020
24
0.670
 Why?
Iodine Compounds
1
2020
7
0.650
 Why?
Brain Edema
1
2020
40
0.620
 Why?
Contrast Media
1
2020
178
0.580
 Why?
Brain Ischemia
4
2022
162
0.580
 Why?
Mucopolysaccharidosis II
1
2018
1
0.580
 Why?
Cardiology
1
2020
106
0.570
 Why?
Medicare
1
2020
280
0.560
 Why?
Coronary Angiography
1
2020
369
0.560
 Why?
Physicians
1
2020
242
0.510
 Why?
Hospitalization
6
2022
749
0.440
 Why?
Humans
31
2025
53230
0.390
 Why?
Databases, Factual
3
2020
742
0.380
 Why?
Telemedicine
1
2019
512
0.370
 Why?
Aged
12
2025
10429
0.370
 Why?
Headache
2
2022
75
0.330
 Why?
Time Factors
4
2020
2991
0.320
 Why?
Autoimmune Diseases
2
2020
90
0.310
 Why?
Ischemic Attack, Transient
2
2020
59
0.300
 Why?
United States
7
2025
5409
0.300
 Why?
Immunosuppressive Agents
2
2020
253
0.290
 Why?
Female
18
2025
28782
0.280
 Why?
Male
16
2025
27435
0.270
 Why?
Middle Aged
13
2025
13419
0.260
 Why?
Cerebral Hemorrhage
2
2025
102
0.260
 Why?
Arkansas
4
2019
2068
0.240
 Why?
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor
1
2025
2
0.230
 Why?
Frontotemporal Dementia
1
2025
4
0.230
 Why?
Emergency Service, Hospital
2
2020
530
0.230
 Why?
Secondary Prevention
1
2025
85
0.220
 Why?
Gastrointestinal Hemorrhage
1
2025
91
0.220
 Why?
Tomography, X-Ray Computed
2
2020
1180
0.210
 Why?
Triage
2
2021
65
0.200
 Why?
Platelet Aggregation Inhibitors
1
2025
213
0.200
 Why?
Retrospective Studies
6
2025
6819
0.200
 Why?
Drug Industry
2
2020
39
0.200
 Why?
Thrombectomy
2
2020
74
0.200
 Why?
Atrial Fibrillation
1
2025
197
0.190
 Why?
Neuroimaging
2
2020
95
0.190
 Why?
Anticoagulants
1
2025
280
0.190
 Why?
Critical Care
2
2021
215
0.180
 Why?
Aged, 80 and over
4
2025
3494
0.170
 Why?
Sinus Thrombosis, Intracranial
1
2021
18
0.170
 Why?
Myasthenia Gravis
1
2021
18
0.170
 Why?
Intracranial Thrombosis
1
2020
16
0.170
 Why?
Hospitalists
1
2020
14
0.170
 Why?
Ageusia
1
2020
6
0.160
 Why?
Olfaction Disorders
1
2020
7
0.160
 Why?
Myocardial Infarction
2
2025
445
0.160
 Why?
Neuromuscular Diseases
1
2020
31
0.160
 Why?
Health Services Misuse
1
2020
13
0.160
 Why?
Osmolar Concentration
1
2020
61
0.160
 Why?
Lymphoma, Non-Hodgkin
1
2020
58
0.160
 Why?
Health Care Sector
1
2020
15
0.160
 Why?
Neurologic Examination
1
2020
75
0.160
 Why?
Infarction, Middle Cerebral Artery
1
2020
41
0.160
 Why?
Mood Disorders
1
2020
60
0.160
 Why?
Multiple Sclerosis
1
2020
77
0.150
 Why?
Patient Transfer
1
2020
99
0.150
 Why?
Venous Thrombosis
1
2020
91
0.150
 Why?
Time-to-Treatment
1
2020
81
0.150
 Why?
Brain Diseases
1
2020
85
0.150
 Why?
Subarachnoid Hemorrhage
1
2020
57
0.150
 Why?
Drug-Eluting Stents
1
2020
101
0.150
 Why?
Young Adult
2
2020
4511
0.150
 Why?
Recombinant Fusion Proteins
1
2010
175
0.150
 Why?
Fabry Disease
1
2019
9
0.150
 Why?
Enzyme Replacement Therapy
1
2019
17
0.150
 Why?
Hospitals
1
2020
181
0.150
 Why?
Suicidal Ideation
1
2020
120
0.150
 Why?
Nervous System Diseases
1
2020
93
0.150
 Why?
Angiogenesis Inhibitors
1
2010
186
0.140
 Why?
Tomography Scanners, X-Ray Computed
1
2018
11
0.140
 Why?
Fluorocarbons
1
2019
65
0.140
 Why?
Angiography, Digital Subtraction
1
2018
28
0.140
 Why?
Seizures
1
2020
203
0.140
 Why?
Neuroprotective Agents
1
2019
101
0.140
 Why?
Pain
1
2020
351
0.140
 Why?
Anxiety
1
2020
321
0.130
 Why?
Pulmonary Disease, Chronic Obstructive
1
2019
152
0.130
 Why?
Meningitis
1
2016
25
0.130
 Why?
Diagnosis, Differential
1
2020
1038
0.130
 Why?
Referral and Consultation
1
2019
299
0.130
 Why?
Adult
6
2025
14534
0.120
 Why?
Antibodies, Monoclonal
1
2010
477
0.120
 Why?
Percutaneous Coronary Intervention
1
2020
329
0.120
 Why?
Ovarian Neoplasms
1
2010
459
0.120
 Why?
Plasma Cells
1
2016
234
0.110
 Why?
Magnetic Resonance Imaging
2
2020
1583
0.110
 Why?
RNA-Directed DNA Polymerase
1
2002
5
0.100
 Why?
Oligodeoxyribonucleotides
1
2002
27
0.090
 Why?
DNA, Complementary
1
2002
128
0.090
 Why?
Adolescent
2
2020
6907
0.090
 Why?
Antineoplastic Agents
1
2010
1232
0.090
 Why?
Mycobacterium tuberculosis
1
2002
250
0.080
 Why?
Treatment Outcome
4
2022
5595
0.080
 Why?
Risk Factors
3
2025
4017
0.080
 Why?
Intubation, Intratracheal
2
2021
116
0.080
 Why?
Risk Assessment
2
2025
1368
0.070
 Why?
Cross-Sectional Studies
2
2025
1723
0.070
 Why?
Cohort Studies
2
2022
1557
0.070
 Why?
Prevalence
2
2020
1034
0.060
 Why?
Receptor, Macrophage Colony-Stimulating Factor
1
2025
5
0.060
 Why?
Mexico
1
2025
38
0.060
 Why?
Propensity Score
1
2025
170
0.050
 Why?
Drug Therapy, Combination
1
2025
405
0.050
 Why?
Intracranial Hemorrhages
1
2022
44
0.050
 Why?
Multiple Myeloma
1
2016
3082
0.050
 Why?
Cranial Sinuses
1
2021
8
0.040
 Why?
Industry
1
2020
16
0.040
 Why?
Arthritis, Psoriatic
1
2020
8
0.040
 Why?
Spondylitis, Ankylosing
1
2020
9
0.040
 Why?
Cranial Nerves
1
2020
14
0.040
 Why?
Disease Susceptibility
1
2021
96
0.040
 Why?
Endocrine System Diseases
1
2010
9
0.040
 Why?
Receptors, Vascular Endothelial Growth Factor
1
2010
26
0.040
 Why?
Mortality
1
2020
98
0.040
 Why?
Colitis, Ulcerative
1
2020
68
0.040
 Why?
Arthritis, Rheumatoid
1
2020
117
0.040
 Why?
Disease Outbreaks
1
2020
120
0.040
 Why?
Maximum Tolerated Dose
1
2019
42
0.040
 Why?
Administration, Oral
1
2020
456
0.040
 Why?
Tertiary Care Centers
1
2019
86
0.040
 Why?
Mutation
1
2025
1337
0.040
 Why?
alpha-Galactosidase
1
2019
9
0.040
 Why?
Administration, Intravenous
1
2019
73
0.040
 Why?
Crohn Disease
1
2020
116
0.040
 Why?
Registries
1
2022
652
0.040
 Why?
Disability Evaluation
1
2019
92
0.040
 Why?
Hemorrhage
1
2020
226
0.040
 Why?
Skin Diseases
1
2010
117
0.040
 Why?
Gastrointestinal Diseases
1
2010
130
0.040
 Why?
Drug Administration Schedule
1
2019
370
0.040
 Why?
Recovery of Function
1
2019
203
0.040
 Why?
Antibodies, Monoclonal, Humanized
1
2010
238
0.030
 Why?
Electronic Health Records
1
2021
287
0.030
 Why?
Comorbidity
1
2019
638
0.030
 Why?
Double-Blind Method
1
2019
729
0.030
 Why?
Patient Readmission
1
2019
251
0.030
 Why?
Prognosis
1
2022
2118
0.030
 Why?
Fatal Outcome
1
2016
193
0.030
 Why?
Follow-Up Studies
1
2020
2318
0.030
 Why?
Prospective Studies
1
2020
2411
0.030
 Why?
Cardiovascular Diseases
1
2010
501
0.030
 Why?
DNA Primers
1
2002
202
0.020
 Why?
Infant
1
2020
3805
0.020
 Why?
Child, Preschool
1
2020
4162
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2002
412
0.020
 Why?
Gene Expression Regulation, Bacterial
1
2002
177
0.020
 Why?
Transcription, Genetic
1
2002
374
0.020
 Why?
RNA, Messenger
1
2002
1133
0.020
 Why?
Child
1
2020
7379
0.020
 Why?
Nalleballe's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (163) concept(s)
_
Co-Authors Expand Description
See all (20) people
_
Similar People Expand Description
See all (36) people
_
Same Department Expand Description
Search Department